BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 14978761)

  • 1. Development and optimization of an adenovirus production process.
    Kamen A; Henry O
    J Gene Med; 2004 Feb; 6 Suppl 1():S184-92. PubMed ID: 14978761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Producing recombinant adenovirus encoding green fluorescent protein (Ad-GFP) by suspension cultured HEK-293 N3S cells].
    Tian B; Wu B; Zhang QW; Bi JJ; Wang L; Zhu BZ; Geng Y; Wu ZZ
    Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):915-8. PubMed ID: 18051875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An efficient and scalable process for helper-dependent adenoviral vector production using polyethylenimine-adenofection.
    Dormond E; Meneses-Acosta A; Jacob D; Durocher Y; Gilbert R; Perrier M; Kamen A
    Biotechnol Bioeng; 2009 Feb; 102(3):800-10. PubMed ID: 18821637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of adenoviral vectors by combined anion exchange and gel filtration chromatography.
    Eglon MN; Duffy AM; O'Brien T; Strappe PM
    J Gene Med; 2009 Nov; 11(11):978-89. PubMed ID: 19670285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-glutamine fed-batch cultures of 293-HEK serum-free suspension cells for adenovirus production.
    Lee YY; Yap MG; Hu WS; Wong KT
    Biotechnol Prog; 2003; 19(2):501-9. PubMed ID: 12675594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures.
    Henry O; Dormond E; Perrier M; Kamen A
    Biotechnol Bioeng; 2004 Jun; 86(7):765-74. PubMed ID: 15162452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-titer adenovirus vector production in 293S cell perfusion culture.
    Cortin V; Thibault J; Jacob D; Garnier A
    Biotechnol Prog; 2004; 20(3):858-63. PubMed ID: 15176892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectors.
    Farson D; Harding TC; Tao L; Liu J; Powell S; Vimal V; Yendluri S; Koprivnikar K; Ho K; Twitty C; Husak P; Lin A; Snyder RO; Donahue BA
    J Gene Med; 2004 Dec; 6(12):1369-81. PubMed ID: 15538729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6 cell culture under sparging conditions.
    Xie L; Metallo C; Warren J; Pilbrough W; Peltier J; Zhong T; Pikus L; Yancy A; Leung J; Auniņs JG; Zhou W
    Biotechnol Bioeng; 2003 Jul; 83(1):45-52. PubMed ID: 12740932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
    Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A
    J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two different serum-free media and osmolality effect upon human 293 cell growth and adenovirus production.
    Ferreira TB; Ferreira AL; Carrondo MJ; Alves PM
    Biotechnol Lett; 2005 Nov; 27(22):1809-13. PubMed ID: 16314975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high-yield and scaleable adenovirus vector production process based on high density perfusion culture of HEK 293 cells as suspended aggregates.
    Liu H; Liu XM; Li SC; Wu BC; Ye LL; Wang QW; Chen ZL
    J Biosci Bioeng; 2009 May; 107(5):524-9. PubMed ID: 19393552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a suspension serum-free helper-dependent adenovirus production system and assessment of co-infection conditions.
    Meneses-Acosta A; Dormond E; Jacob D; Tom R; Bernier A; Perret S; St-Laurent G; Durocher Y; Gilbert R; Kamen A
    J Virol Methods; 2008 Mar; 148(1-2):106-14. PubMed ID: 18079009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications.
    Burova E; Ioffe E
    Gene Ther; 2005 Oct; 12 Suppl 1():S5-17. PubMed ID: 16231055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum-free suspension cultivation of PER.C6(R) cells and recombinant adenovirus production under different pH conditions.
    Xie L; Pilbrough W; Metallo C; Zhong T; Pikus L; Leung J; Auniņs JG; Zhou W
    Biotechnol Bioeng; 2002 Dec; 80(5):569-79. PubMed ID: 12355468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells.
    Côté J; Garnier A; Massie B; Kamen A
    Biotechnol Bioeng; 1998 Sep; 59(5):567-75. PubMed ID: 10099373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot-scale adenovirus seed production through concurrent virus release and concentration by hollow fiber filtration.
    Subramanian S; Altaras GM; Chen J; Hughes BS; Zhou W; Altaras NE
    Biotechnol Prog; 2005; 21(3):851-9. PubMed ID: 15932265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scaleable production of adenoviral vectors by transfection of adherent PER.C6 cells.
    Subramanian S; Kim JJ; Harding F; Altaras GM; Aunins JG; Zhou W
    Biotechnol Prog; 2007; 23(5):1210-7. PubMed ID: 17715941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPLC purification of adenoviral vectors.
    Eglon M; McGrath B; O'Brien T
    Methods Mol Biol; 2010; 594():395-408. PubMed ID: 20072933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manufacturing of adenovirus vectors: production and purification of helper dependent adenovirus.
    Dormond E; Kamen AA
    Methods Mol Biol; 2011; 737():139-56. PubMed ID: 21590396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.